Trump targets drug middlemen with ‘devastating’ rebate overhaul
The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers.
Pharmaceutical
Articles
Harvard study involving Anthem unit finds older insulins are both safe, cheaper
Increasingly, top researchers are questioning whether drugs such as Lantus from Sanofi, Levemir and Novolog from Novo Nordisk A/S, and Humalog from Eli Lilly and Co. are really needed for many patients.
Senators threaten to force drug execs to testify about prices
Sen. Ron Wyden, the ranking Democrat on the committee, singled out Humalog, an insulin made by Indianapolis-based Eli Lilly and Co, as a drug with unwarranted price hikes.
Lilly cancer drug shouldn’t be started in new patients, FDA says
Lartruvo shouldn’t be started in new patients, and those patients already taking it should ask their doctors if they should continue, U.S. regulators said, following a key study that failed to show the medicine prolonged lives.
Senators ask FDA to update rules on CBD, hemp products
Congress legalized the production and sale of industrial hemp and hemp derivatives, including CBD. But FDA Commissioner Scott Gottlieb has restated his agency’s stance that CBD is a drug ingredient and therefore illegal to add to food or health products without his agency’s approval.
Walmart to leave CVS pharmacy network
The dispute between the world’s largest retail chain and the prominent pharmacy-benefits manager could roil the business of filling prescriptions.
Lilly to disclose more information about drug pricing
Eli Lilly and Co. won’t put the price of its prescription drugs in television ads, as the Trump administration has called for pharmaceutical companies to do, but will begin promoting a website where prices are available.
Former Cook Group unit plans $100M expansion, 200 jobs in Indiana
A New Jersey-based company that acquired Cook Group’s drug-delivery technology unit in late 2017 has plans for a major expansion.
Rising fear among Asians leads Eli Lilly to rethink employee groups
New employees at Eli Lilly and Co. get a letter encouraging them to join one of the pharmaceutical firm’s affinity groups. There’s one for African Americans, one for Latino employees—and four for Asians.
State police collect unused medicines
Indiana State Police collected more than a ton of expired and unwanted prescription medications Oct. 27 as part of the national “Prescription Drug Take Back” initiative sponsored by the U.S. Drug Enforcement Administration.
Opioid war rages on, but those on the front lines see progress
The crisis has been years in the making, and the job of wrestling it to the ground has grown into a massive task. No one is yet predicting when the state will be able to declare victory.
Eli Lilly partner urges investors to look beyond biotech turmoil
Look at the future prospects, not the losses, says the CEO of a newly listed Chinese biotech company that’s developing anti-cancer drugs with Indianapolis-based Eli Lilly and Co.
Trump says new proposal will slash some U.S. drug prices
President Donald Trump said he was “taking aim at the global freeloading that forces American consumers to subsidize lower prices in foreign countries through higher prices in our country.”
Trump focusing on drug prices, high among voters’ concerns
President Donald Trump is linking the drug prices Americans complain about to one of his longstanding grievances: foreign countries the president says are taking advantage of U.S. research breakthroughs.
Opioid alternative from Lilly, Pfizer shows promise in study
The experimental drug eased arthritis pain in hard-to-treat patients without major safety concerns, a key step in creating a new class of medications that may one day offer an alternative to narcotics.
U.S. wants drug prices in TV ads: ‘Patients deserve to know’
The drug industry's main trade group said drug companies are only willing to disclose the prices on their websites, not in commercials, and they'll start doing that next spring.
Deal with national pharmacy spurs tech company’s growth
An Indianapolis-based company has signed a deal with national mail-order pharmacy GoGoMeds that officials project will help double its local workforce—to about 250—within five years.
Lilly might market diabetes drug for obesity after research results
Eli Lilly and Co.’s stock jumped Thursday after midstage research on an experimental diabetes drug showed significant weight loss in patients. The news took a toll on shares of rival Novo Nordisk.
Opioid epidemic showing signs of turning corner, state drug czar says
Visits to emergency rooms in Indiana for drug overdoses are falling, and doctors are writing fewer prescriptions for opioid painkillers, Jim McClelland said Friday.
Migraine drug from Eli Lilly approved by FDA
Eli Lilly and Co. received clearance Thursday from U.S. regulators for a new migraine drug that will be the third in a promising class of therapies for patients who suffer from the recurrent, painful headaches.